A new study on harms resulting from the COVID vaccine was published on April 8 in the U.S.-based peer-reviewed medical science journal Cureus. It represents the largest study to date on adverse effects of the COVID vaccine, and the results are shocking, to put it mildly.
In the study, titled “Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan,” five Japanese scientists used an entire dataset of the country’s 123 million population (Japan has the highest vaccination rate in the world) to study excess cancer mortalities coinciding with mass COVID vaccination.
The authors also provide a sound explanation as to why these deaths occurred after the mRNA injection.
As a former vaccine researcher, I read the Cureus article with great interest. My fellow Epoch Times columnist, Megan Redshaw, has written an excellent article on this study. Here, I would like to highlight some points that I think are worth reiterating.
The study shows there were 1,568,961 total deaths in Japan in 2022. About 1,453,162 deaths were expected based on statistical predictions using pre-pandemic information, which means there were 115,799 excess deaths in 2022.
The 115,799 “age-adjusted excess number of deaths” in 2022 occurred after two-thirds of the Japanese population had received the third dose of COVID vaccine.
Based on Japan’s Ministry of Health data, I calculated that there were 39,060 COVID deaths reported in 2022. So, the majority of Japan’s excess deaths in 2022 were not caused by COVID infection, but rather are strongly associated with the vaccination.
The study shows that in 2020, after COVID-19 began to spread in Japan but before vaccination was available, the age-adjusted number of deaths was 28,000 fewer than what was predicted. And in 2021, as the virus continued and there was limited COVID-19 vaccination (it started in February), there were 25,000 more deaths than what was predicted.
Based on the number of excess deaths in 2022, the Japanese scientists concluded: “Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine.”
“These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination rather than COVID-19 infection itself or reduced cancer care due to the lockdown,” the authors wrote.
In plain English, this study revealed the mRNA COVID jab is likely the cause of the extra deaths that occurred in Japan.
The study presented the numbers for all-cause death, but also looked into the details of deaths caused by cancer. It found that of the 20 types of cancer, six of them—ovarian, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancer—had statistically significant excess mortalities in 2021 and increased further in 2022.
The significant increase in mortalities for the six specific cancer types cannot be blamed on a shortage of health-care services during the pandemic. Reduced cancer screening and health care due to lockdowns should increase deaths for all cancers. However, such an increase was not observed in other types of cancers in Japan in 2022.
So what is so special about the six specific cancer types? They are all known as estrogen receptor alpha (ERα)-sensitive cancers.
The scientists explained why these cancers not only occurred after vaccination, but also killed people in a short period of time after they received the shot.
I worked as a research scientist at Sanofi Pasteur, one of the world’s largest vaccine companies, for more than 10 years. As the person who spearheaded Sanofi’s SARS-CoV-1 vaccine development in 2003, I personally found the hypothesis presented by the Japanese scientists very reasonable.
Please bear with me on the scientific terms, because they are important in understanding the possible roles the mRNA vaccine may have played in cancer development.
ERs (estrogen receptors) are a group of proteins found inside cells. They are receptors that can be activated by the sex hormone estrogen. ERα is one of the two classes of ERs, an important regulator in the body’s reproductive system.
Research published in the peer-reviewed journal Science Advances in November 2022 screened 9,000 human proteins to see which protein binds better with the spike (S) protein of SARS-CoV-2, and found the S protein specifically binds to ERα. The binding “upregulates the transcriptional activity of ERα.”
In other words, the S protein of SARS-CoV-2 (from infection or vaccination), when introduced into the human body, binds to ERα and functions as a nuclear receptor coregulator, interfering with the cell’s normal function and leading to malfunction of the cells and organs.
This may explain why death caused by the six types of ERα-sensitive cancers increased in 2022 in Japan after two-thirds of the population received the third dose of the mRNA vaccine.
The vaccine carries the S gene of SARS-CoV-2, hijacking the host cells to produce S proteins. The S proteins produce inside the cell, then bind to ERα, disrupting the cell’s normal function and leading to cancer development.
Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body.
For any healthy person, some cells die, some age, and some become cancerous. All this happens without the person knowing it because the body’s immune system is constantly working to deal with such problems. However, if the immune system is compromised, illness then develops, including cancer.
Plenty of evidence has started to emerge showing that the COVID-19 vaccine has the potential to severely interfere with the human body’s immune system. This new Japanese study provides further evidence of the extent of this phenomenon.
